Viewing Study NCT02443467


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-27 @ 4:02 AM
Study NCT ID: NCT02443467
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2015-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module